Axsome Therapeutics Inc (GB:0HKF)

Axsome Therapeutics (0HKF) Financial Statements


Axsome Therapeutics Financial Overview

Axsome Therapeutics's market cap is currently ―. The company's EPS TTM is $; its P/E ratio is ―; Axsome Therapeutics is scheduled to report earnings on August 9, 2023, and the estimated EPS forecast is $-1.27. See an overview of income statement, balance sheet, and cash flow financials.
Mar 23Dec 22Sep 22Jun 22Mar 22
Income Statement-
Total Revenue$ 94.58M$ 24.37M$ 16.85M$ 8.82M$ 0.00
Gross Profit$ 94.74M$ 20.17M$ 14.92M$ 7.84M-
EBIT$ -6.37M$ -54.72M$ -42.41M$ -39.18M$ -38.29M
EBITDA$ -4.80M$ -53.11M$ -40.45M$ -37.91M$ -37.98M
Net Income Common Stockholders$ -11.22M$ -61.24M$ -44.82M$ -41.44M$ -39.63M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 246.51M$ 200.84M$ 227.52M$ 73.39M$ 84.71M
Total Assets$ 388.48M$ 331.48M$ 338.96M$ 180.56M$ 88.56M
Total Debt$ 147.72M$ 94.68M$ 94.33M$ 94.17M$ 50.28M
Net Debt$ -98.79M$ -106.16M$ -133.19M$ 20.77M$ -34.43M
Total Liabilities$ 277.37M$ 221.92M$ 181.60M$ 165.36M$ 73.86M
Stockholders Equity$ 111.76M$ 109.56M$ 157.36M$ 15.20M$ 14.70M
Cash Flow-
Free Cash Flow$ -5.89M$ -27.74M$ -22.82M$ -33.78M$ -32.87M
Operating Cash Flow$ -5.82M$ -27.56M$ -22.76M$ -33.54M$ -32.65M
Investing Cash Flow$ -71.00K$ -180.86K$ -66.06K$ -53.24M$ -213.74K
Financing Cash Flow$ 51.56M$ 1.07M$ 176.95M$ 75.46M$ 31.10M
Currency in USD

Axsome Therapeutics Earnings and Revenue History

Axsome Therapeutics Debt to Assets

Axsome Therapeutics Cash Flow

Axsome Therapeutics Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis